prandd

Breast cancer: new compound could enhance the efficacy of standard treatment

Physician-scientists from the Karl Landsteiner University of Health Sciences, Krems (Austria) together with colleagues from Germany, US and China demonstrate promising pre-clinical activity of a novel anti-breast cancer drug. Krems (Austria), December 12, 2018 – A novel compound against breast cancer improves the efficacy of standard cancer treatment and shows superior tolerability in laboratory tests…

contextflow selected for Philips HealthWorks AI in Radiology Accelerator

Deep learning expert contextflow GmbH thrilled to announce its participation in highly-selective program with one of the world’s leading health innovation companies Vienna, Austria, December 5th 2018 – contextflow, a recognized name in the highly competitive field of AI in medical image processing, is one of only 19 startups from 14 countries invited to participate…

Award for phage therapy: PhagoMed wins Austrian Entrepreneurship Award Phönix

Vienna, 4 December 2018: Vienna-based Biotech company PhagoMed Biopharma GmbH was yesterday awarded the Austrian Entrepreneurship Award Phönix 2018 in the category “Start-Up International”. The Phoenix award honours the development of antibiotics alternatives based on phages, a class of natural viruses that only infect bacteria, at the Vienna Biocenter. A distinguished jury selected PhagoMed as…

Viennese biotech company Marinomed demonstrates the benefits of its patented Marinosolv technology

Solubilization of the immunomodulator tacrolimus up to 200 times greater using Marinosolv® • Bioavailability in the eye up to 15 times higher under laboratory conditions when compared to commercially available alternative treatments • Findings published in the European Journal of Pharmaceutics and Biopharmaceutics • Clinical trial for Tacrosolv, a tacrolimus-based product candidate against allergic conjunctivitis,…

Psychological intervention study: even brief abstinence from social media causes withdrawal symptoms

Researchers from Karl Landsteiner University of Health Sciences identify addiction-like behaviour after time away from social media Krems (Austria), 14 November 2018 – In many cases, just a seven-day break from social media platforms such as Facebook and WhatsApp is sufficient to induce withdrawal symptoms like those caused by addictive substances. This is the conclusion…

Europe and USA: agreement on definition and diagnosis of specific form of high blood pressure

Physician from Karl Landsteiner University of Health Sciences plays a part in global consensus-building process Krems (Austria), 6 November 2018 – A transcontinental agreement was recently reached on the definition and diagnosis of a particular form of high blood pressure. Until now, it was difficult to outline a generally accepted set of symptoms – and…

Donor Organs on Demand: Research Looks at Lifelike Organ Models Produced on 3D Printers

Biomedical engineers from Karl Landsteiner University of Health Sciences in Krems launch project focused on 3D printing of tissue models Krems, 02 October 2018 – A research project recently initiated at Karl Landsteiner University of Health Sciences aims to produce organ models with realistic material properties. These biological replicas will mainly be deployed in research…

On the “shelf life” of water: Hot on the trail of the biostability of water using state-of-the-art DNA and cell analysis

Karl Landsteiner University of Health Sciences in Krems launches project to study the growth of water-based microorganisms  Krems (Austria), 9 August 2018 – In order to better understand and assess the quality of ground and spring water, state-of-the-art methods from the fields of molecular biology and microbiology, as well as chemical high-performance analytics are now…

Clinical Results of Neurodegenerative Study

AFFiRiS Announces Results of a Phase I Clinical Study Using AFFITOPEs® PD01A and PD03A, Confirming Safety and Tolerability for Both Compounds as well as Immunogenicity for PD01A in Early MSA patients AFFITOPEs® PD01A and PD03A Safe and Well Tolerated: Primary Endpoint of Phase I Study Met Immune Response against AFFITOPE® PD01A and Alpha-Synuclein Seen in…

Unconditionally, Ernst Toller

Unconditionally, Ernst TollerErnst Toller was a revolutionary, a man of letters, a politician and an indefatigable writer of letters. With the support of the Austrian Science Fund FWF, a collection of his correspondence between 1915 and 1939 has now been edited with a commentary. It opens up a 24-year window to a period of radical…